{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/us-fda-grants-priority-review-to-sbla-for-padcev--keytruda-as-perioperative-treatment-for-muscle-invasive-bladder-cancer-regardless-of-cisplatin-eligibility-302746360.html", "message": "News view counter 670953 successfully enlarged"}